
AVAH Stock Forecast & Price Target
AVAH Analyst Ratings
Bulls say
Aveanna Healthcare Holdings Inc. reported a revenue rate of $495.43, representing a 0.6% increase, with a gross margin improvement to 32.6%, surpassing expectations, and benefiting from strong performance in Private Duty Services (PDS). The Home Health & Hospice (HHH) segment experienced robust growth, with revenue reaching $62.4 million, up 15.3% year-over-year, driven by a notable increase in both total and episodic admissions. Furthermore, the company has raised its guidance, now forecasting revenue of over $2.375 billion, indicating a positive outlook on its financial health and growth trajectory.
Bears say
Aveanna Healthcare Holdings Inc. faces significant downside risks that contribute to a negative outlook on its stock, including potential reimbursement pressures and high leverage. Additionally, labor headwinds are expected to negatively impact adjusted EBITDA estimates by approximately 10% in fiscal year 2026, while gross margins have shown a decline year-over-year. The company's anticipated challenges with organic growth, regulatory issues, and increased competition further exacerbate concerns over its financial stability and operational effectiveness.
This aggregate rating is based on analysts' research of Aveanna Healthcare Holdings and is not a guaranteed prediction by Public.com or investment advice.
AVAH Analyst Forecast & Price Prediction
Start investing in AVAH
Order type
Buy in
Order amount
Est. shares
0 shares